Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 10760308)

1.

Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK.

N Engl J Med. 2000 Apr 13;342(15):1077-84.

2.

Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor.

Pereira Nunes Mdo C, Barbosa MM, Ribeiro AL, Amorim Fenelon LM, Rocha MO.

Rev Esp Cardiol. 2010 Jul;63(7):788-97. English, Spanish.

3.

Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, Shimamoto K.

J Nucl Med. 2001 Dec;42(12):1757-67.

4.

Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ.

Am J Cardiol. 1997 Jun 15;79(12):1645-50.

PMID:
9202356
5.
6.

Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry.

Aleksova A, Sabbadini G, Merlo M, Pinamonti B, Barbati G, Zecchin M, Bussani R, Silvestri F, Iorio AM, Stolfo D, Dal Ferro M, Dragos AM, Meringolo G, Pyxaras S, Lo Giudice F, Perkan A, di Lenarda A, Sinagra G.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):699-705. doi: 10.2459/JCM.0b013e32832bba35.

PMID:
19474760
7.

Wall motion abnormalities with low-dose dobutamine predict a high risk of cardiac death in medically treated patients with ischemic cardiomyopathy.

Maskoun W, Mustafa N, Mahenthiran J, Gradus-Pizlo I, Kamalesh M, Feigenbaum H, Sawada SG.

Clin Cardiol. 2009 Jul;32(7):403-9. doi: 10.1002/clc.20558.

PMID:
19609896
8.

Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.

Elhendy A, Sozzi F, van Domburg RT, Bax JJ, Schinkel AF, Roelandt JR, Poldermans D.

Am J Cardiol. 2005 Aug 15;96(4):469-73.

PMID:
16098295
9.

Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.

Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY.

JACC Cardiovasc Imaging. 2009 Jan;2(1):34-44. doi: 10.1016/j.jcmg.2008.09.010.

10.

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ.

J Am Coll Cardiol. 2001 Aug;38(2):421-8.

11.

The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.

Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, Haffner S, Katz R, Lindenfeld J, Lowes BD, Martin W, McGrew F, Bristow MR; BEST Investigators.

J Am Coll Cardiol. 2003 Sep 3;42(5):914-22.

PMID:
12957443
12.

Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk.

Cappola TP, Felker GM, Kao WH, Hare JM, Baughman KL, Kasper EK.

Circulation. 2002 Apr 9;105(14):1663-8.

13.

Sex-based differences in the effect of digoxin for the treatment of heart failure.

Rathore SS, Wang Y, Krumholz HM.

N Engl J Med. 2002 Oct 31;347(18):1403-11.

14.

Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction--comparison with nonischemic cardiomyopathy.

Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, Shirato K.

Circ J. 2005 Feb;69(2):143-9.

15.

Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.

Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F; ALPHA Study Group Investigators.

J Am Coll Cardiol. 2007 Nov 6;50(19):1896-904. Epub 2007 Oct 22.

16.

Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Anastasiou-Nana MI, Terrovitis JV, Athanasoulis T, Karaloizos L, Geramoutsos A, Pappa L, Tsagalou EP, Efentakis S, Nanas JN.

Am J Cardiol. 2005 Aug 1;96(3):427-31.

PMID:
16054475
17.

Incidence and prognosis of syncope.

Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D.

N Engl J Med. 2002 Sep 19;347(12):878-85.

18.

Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.

Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C.

Circulation. 2003 Jul 22;108(3):305-12. Epub 2003 Jun 30.

19.

Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.

Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O'Connor CM.

J Am Coll Cardiol. 1997 Oct;30(4):1002-8.

20.

Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group.

Brouwer J, van Veldhuisen DJ, Man in 't Veld AJ, Haaksma J, Dijk WA, Visser KR, Boomsma F, Dunselman PH.

J Am Coll Cardiol. 1996 Nov 1;28(5):1183-9.

PMID:
8890814
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk